Branden Reid, PhD

Branden Reid, PhD

Director Global Regulatory Affairs @ AstraZeneca

About

Innovative, assertive and high performing professional who offers a multi-faceted scientific background coupled with diverse regulatory expertise. Demonstrated ability to identify, focus, and develop tactical and strategic solutions. Strategist adept at evaluating medical need and delivering timely approvals in an evolving regulatory landscape and marketplace. Accomplished communicator capable of managing complex situations and reconciling competing interests in a highly matrixed global environment.

Country

United States

City

Fulton

Industry

Pharmaceuticals

Skill

Biomedical Engineering, Biomaterials, PCR, Tissue Engineering, Cell Culture, Western Blotting, Medical Devices, Cell, Stem Cells, Tissue Culture, AFM, Biotechnology, Flow Cytometry, Validation, Fluorescence Microscopy, Regenerative Medicine, Scanning Electron Microscopy, Clinical Trials, Chemistry, Laboratory

Experience

AstraZeneca

Director Global Regulatory Affairs

AstraZeneca

LinkedIn
2021-7 - Present · 5 yrs 3 mos

Cell Therapy

Vertex Pharmaceuticals

Associate Director, Global Regulatory Strategy

Vertex Pharmaceuticals

LinkedIn
2020-5 - 2021-7 · 1 yr 3 mos
Johnson & Johnson Innovative Medicine

Associate Director, Global Regulatory Affairs, Combination Products

Johnson & Johnson Innovative Medicine

LinkedIn
2017-8 - 2020-4 · 2 yrs 9 mos
BD

Regulatory Affairs

BD

LinkedIn
2014-10 - 2017-8 · 2 yrs 11 mos

Franklin Lakes, NJ

BD Life Sciences – Preanalytical Systems

FDA

Medical Device Reviewer

FDA

LinkedIn
2012-8 - 2014-9 · 2 yrs 2 mos

Silver Spring, MD

The Johns Hopkins University School of Medicine

Post Doctoral Fellow

The Johns Hopkins University School of Medicine

LinkedIn
2012-4 - 2012-7 · 4 mos
Johns Hopkins University

Graduate Student Researcher

Johns Hopkins University

2006 - 2012 · 6 yrs

Thesis title: Redox Chemistry in Biomaterials and Tissue Engineering Thesis work involved the design of novel biomaterials, stem cell manipulation for tissue regeneration, and a multitude of clinical applications and developments in collaboration with industry including one device that went into a pilot clinical trial. Publications: B. Reid, M. Gibson, A. Singh, J. Taube, C. Furlong, M. Murcia, J. Elisseeff. (2013), PEG hydrogel degradation and the role of the surrounding tissue environment. Journal of Tissue Engineering and Regenerative Medicine. B. Reid, J. Afzal, A. McCartney, R. Abraham, B. O'Rourke, and J. Elisseeff. (2013), Enhanced tissue production through redox control in stem cell-laden hydrogels. Tissue Engineering Part A. Hillel, A. T., Nahas, Z., Unterman, S., Reid, B., Axelman, J., Sutton, D., Matheson, C., Petsche, J. and Elisseeff, J. H. (2012), Validation of a Small Animal Model for Soft Tissue Filler Characterization. Dermatologic Surgery. A. Hillel, Z. Nahas, S. Unterman, B. Reid, J. Coburn, J. Axelman, J. Chae, Q. Guo, J. Elisseeff. (2011), Photoactivated Composite Biomaterial for Soft Tissue Restoration in Rodents and in Humans. Science Translational Medicine. B. Reid, S. Tzeng, A. Warren, K. Kozielski, J. Elisseeff. (2010), Development of a PEG Derivative Containing Hydrolytically Degradable Hemiacetals. Macromolecules. E. Waddell, S. Shreeves, H. Carrell, C. Perry, B. Reid, J. McKee. (2008), Surface modification of Sylgard 184 polydimethylsiloxane by 254 nm excimer radiation and characterization by contact angle goniometry, infrared spectroscopy, atomic force and scanning electron microscopy. Applied Surface Science. Reid B. and Elisseeff J. (2011) Biomaterials in Cartilage Tissue Engineering. In: P. Ducheyne, K.E. Healy, D.W. Hutmacher, D.W. Grainger, C.J. Kirkpatrick (eds.) Comprehensive Biomaterials, vol. 5, pp. 213-220 Elsevier. B. Reid, J. Elisseeff. ROPEG – Hydrolytically Degradable PEG Derivative. Patent Pending

Education

The Johns Hopkins University School of Medicine

The Johns Hopkins University School of Medicine

LinkedIn

Biomedical Engineering

2006 - 2012 · 6 yrs

Advisor: Dr. Jennifer Elisseeff, PhD •Modulated stem cell metabolism to enhance bone tissue •Investigated redox-mediated degradation of poly (ethylene glycol)-based hydrogels and the role of the surrounding tissue environment •Synthesized a poly (ethylene glycol) derivative containing hydrolytically degradable hemiacetals •Developed Kythera Biopharmaceutical ATX-104 light-activated facial contouring agent with a team of medical doctors, scientists, management, and executive members of Kythera Biopharmaceuticals. The device was evaluated in a pilot clinical trial. •Conducted peer-review of manuscripts for my principal investigator, Jennifer Elisseeff, PhD

Morgan State University

Morgan State University

LinkedIn

Engineering Physics

2002 - 2006 · 4 yrs

Branden Reid, PhD's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.